A Study of LY2801653 in Healthy Participants Who Are Not Able to Have Children
Completed · Phase 1
Conditions studied: Healthy
In brief
The purpose of this study is to evaluate how much of the LY2801653 drug is available in the body when given in 2 different formulations with and without a meal to healthy participants who are not able to have children. In addition, this study will measure how much of the drug gets into the blood stream and how long it takes the body to get rid of it. Information about any side effects that may occur will also be collected. The study will last about 27 days. Screening is required within 28 days prior to the start of the study.
Key facts
- Study ID
- NCT02370485
- Run by
- Eli Lilly and Company
- People needed
- 23
- Starts
- 2015-02-01
- Expected to finish
- 2015-05-01
- Last updated by the study team
- 2015-06-19
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Generally healthy sterile male and female participants
- Body mass index (BMI) of 18.0 to 32.0 kilograms per square meter (kg/m\^2), inclusive
- Are willing and able to eat the protocol specified high-fat breakfast
You may not qualify if…
- Have consumed grapefruits or grapefruit-containing products, Seville oranges or Seville orange juice, star fruit, star fruit juice, or star fruit-containing products, or commercial apple or orange juice within 14 days prior to first dosing
- Regularly use known drugs of abuse and/or show positive findings on urinary drug screening
- Have donated blood of more than 500 milliliter (mL) within the last month
Where it is running
- Covance — Daytona Beach, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.